Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)

The summary for the Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41): The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business grant applications to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.
Federal Grant Title: Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-17-200
Type of Funding: Grant
CFDA Numbers: 93.173, 93.865
CFDA Descriptions: Information not provided
Current Application Deadline: January 5th, 2020
Original Application Deadline: January 5th, 2020
Posted Date: March 29th, 2017
Creation Date: March 29th, 2017
Archive Date: February 10th, 2020
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: March 29th, 2017
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PAR-17-200.html
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com